Altheia Science

📍 Milano, Italy🗓 Founded 2017👥 5 employees💰 Last funded Dec 2017
Biotechnology Research🌐 altheiascience.com
Website LinkedIn
Altheia Science is a pioneering start-up founded by two world renowned Italian scientists, Prof. Alessandra Biffi, MD and Prof. Paolo Fiorina, MD, PhD, together with AurorA-TT. Altheia Science’s pipeline exploits pioneering therapeutic tools for autoimmune diseases and cancer. The modulation of PD-L1 expression at the molecular and protein level is key to devise advanced treatments. This can be achieved by first-in-class molecules controlling the PD-L1 pathway and/or by lentiviral vector-based engineering of patients’ hematopoietic stem cells. Altheia Science’s approach intends to drastically modify the natural history of diseases with high clinical impact in autoimmunity and cancer by modulating PD-L1 expression, achieving tangible and durable benefit for each patient.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Italy
1
Frequently asked questions
Who invested in Altheia Science?
Altheia Science has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Altheia Science last raise funding?
The most recent investment in Altheia Science recorded on gritt.io was in December 2017.
When was Altheia Science founded?
Altheia Science was founded in 2017.
What industry is Altheia Science in?
Altheia Science operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Altheia Science based?
Altheia Science is headquartered in Milano, Italy.